Published in Biochem Biophys Res Commun on November 15, 1994
Subtype 2 and atypical angiotensin receptors in the human heart. Basic Res Cardiol (1996) 0.78
Neuroendocrine activation after myocardial infarction: causes and consequences. Heart (1996) 0.75
Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation (1999) 3.44
Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients. Circulation (2001) 3.25
Noninvasive detection of myocardial ischemia from perfusion reserve based on cardiovascular magnetic resonance. Circulation (2000) 2.49
Babesiosis: recent insights into an ancient disease. Int J Parasitol (2008) 2.08
[Anticoagulation and thrombophilia in pregnancy]. Internist (Berl) (2008) 2.06
Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation (2004) 2.04
Myocardial catecholamine content after heart transplantation. Circulation (1990) 1.69
Bradykinin B2BKR receptor polymorphism and left-ventricular growth response. Lancet (2001) 1.67
Evidence for the participation of cytochrome b 5 in hepatic microsomal mixed-function oxidation reactions. Arch Biochem Biophys (1971) 1.63
Total occlusion trial with angioplasty by using laser guidewire. The TOTAL trial. Eur Heart J (2000) 1.54
Intracellular energetic units in red muscle cells. Biochem J (2001) 1.53
Functional gene testing of the Glu298Asp polymorphism of the endothelial NO synthase. J Hypertens (2000) 1.49
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial Europe. Eur Heart J (2001) 1.42
[Long-term outcome after coronary emergency intervention]. Dtsch Med Wochenschr (2000) 1.38
Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting. The full anticoagulation versus aspirin and ticlopidine (fantastic) study. Circulation (1998) 1.37
Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents. J Magn Reson Imaging (2001) 1.37
Angiotensin II induces migration and Pyk2/paxillin phosphorylation of human monocytes. Hypertension (2001) 1.32
Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet (2003) 1.28
Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J Am Coll Cardiol (2001) 1.24
Investigation of coronary venous anatomy by retrograde venography in patients with malignant ventricular tachycardia. Circulation (2001) 1.22
Assessment of diffuse coronary artery disease by quantitative analysis of coronary morphology based upon 3-D reconstruction from biplane angiograms. IEEE Trans Med Imaging (1995) 1.20
PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. J Cardiovasc Pharmacol (1999) 1.15
Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation (1997) 1.15
TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases 1/2. Atherosclerosis (2001) 1.14
Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension (1997) 1.14
Transvenous biventricular defibrillation halves energy requirements in patients. Circulation (2001) 1.12
The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function. J Biol Chem (2001) 1.12
Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. Eur J Pharmacol (2000) 1.12
Should stimulation site be tailored in the individual heart failure patient? Am J Cardiol (2000) 1.11
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The cholesterol lowering atherosclerosis PTCA trial (CLAPT). Eur Heart J (1999) 1.10
Cytochrome P-450 of liver microsomes--one pigment or many. Biochem Biophys Res Commun (1968) 1.09
[Policy paper to the cardiac re-sychronization therapy]. Z Kardiol (2003) 1.09
Comparison of magnetic resonance real-time imaging of left ventricular function with conventional magnetic resonance imaging and echocardiography. Am J Cardiol (2001) 1.08
Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart. Cardiovasc Res (2000) 1.07
Nucleotide sequences of the 23S rRNA genes from Bordetella pertussis, B.parapertussis, B.bronchiseptica and B.avium, and their implications for phylogenetic analysis. Nucleic Acids Res (1993) 1.06
A morphogen for the sporulation of Physarum polycephalum detected by cell fusion experiments. Exp Cell Res (1986) 1.05
Reentrant condensation of proteins in solution induced by multivalent counterions. Phys Rev Lett (2008) 1.05
TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension (1999) 1.04
Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation (1993) 1.04
Improvement of myocardial perfusion reserve early after coronary intervention: assessment with cardiac magnetic resonance imaging. J Am Coll Cardiol (2000) 1.04
Coronary arterial stents: safety and artifacts during MR imaging. Radiology (2000) 1.03
Optimization of realtime adaptive navigator correction for 3D magnetic resonance coronary angiography. Magn Reson Med (1999) 1.01
Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol (2001) 1.01
L-selectin-dependent leukocyte adhesion to microvascular but not to macrovascular endothelial cells of the human coronary system. Blood (1997) 1.00
Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration. J Cardiovasc Pharmacol (2001) 0.98
Magnetic resonance real-time imaging for the evaluation of left ventricular function. J Cardiovasc Magn Reson (2000) 0.97
Validation of an accurate method for three-dimensional reconstruction and quantitative assessment of volumes, lengths and diameters of coronary vascular branches and segments from biplane angiographic projections. Int J Card Imaging (1999) 0.97
Angiotensin II-induced leukocyte adhesion on human coronary endothelial cells is mediated by E-selectin. Circ Res (1997) 0.97
Implementation of pharmacotherapy guidelines in heart failure: experience from the German Competence Network Heart Failure. Clin Res Cardiol (2011) 0.96
15-Deoxyspergualin for induction of graft nonreactivity after cardiac and renal allotransplantation in primates. Transplantation (1990) 0.96
In vivo measurement of endothelium-dependent vasodilation with substance P in man. Herz (1992) 0.95
Gender-specific predictors of early mortality after coronary artery bypass graft surgery. Clin Res Cardiol (2012) 0.95
Detection of polycyclic aromatic hydrocarbon degradation genes in different soil bacteria by polymerase chain reaction and DNA hybridization. FEMS Microbiol Lett (1999) 0.94
Central role of the MAPK pathway in ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol (1999) 0.94
Representation of amino acid sequences as two-dimensional point patterns. Electrophoresis (1997) 0.92
Effects of renovascular hypertension on myocardial protein patterns: analysis by computer-assisted two-dimensional gel electrophoresis. Electrophoresis (1998) 0.92
[Comparison of various parameters for determining an index of myocardial perfusion reserve in detecting coronary stenosis with cardiovascular magnetic resonance tomography]. Z Kardiol (2001) 0.91
Genetic polymorphisms of the angiotensin II type 1 (AT1) receptor gene. Eur Heart J (1994) 0.91
Oxygen interaction with reduced cytochrome P-450. Hoppe Seylers Z Physiol Chem (1968) 0.91
Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy. Circulation (2000) 0.91
Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation (1995) 0.90
Doxazosin inhibits monocyte chemotactic protein 1-directed migration of human monocytes. J Cardiovasc Pharmacol (2001) 0.89
Dobutamine stress magnetic resonance imaging for the detection of coronary artery disease in women. Heart (2009) 0.89
[Reimbursement questions for cardiology services within the scope of GOA:2. Position of the DRG and GOA Project Group]. Z Kardiol (2003) 0.88
Determination of carbaryl in natural water samples by a surface plasmon resonance flow-through immunosensor. Biosens Bioelectron (2005) 0.88
Noninvasive determination of coronary blood flow velocity with magnetic resonance imaging: comparison of breath-hold and navigator techniques with intravascular ultrasound. Magn Reson Med (1999) 0.88
Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart. J Heart Transplant (1991) 0.88
Treating poststernotomy mediastinitis by transposition of the greater omentum: late angiographic findings. J Card Surg (1995) 0.88
Isolation and characterization of macrovascular and microvascular endothelial cells from human hearts. Am J Physiol (1994) 0.87
Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy. Circulation (2000) 0.87
Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. Am J Cardiol (2001) 0.87
Regulation and differential expression of neutral endopeptidase 24.11 in human endothelial cells. Hypertension (1995) 0.87
Retracted Established and emerging pathogens in Ixodes ricinus ticks collected from birds on a conservation island in the Baltic Sea. Med Vet Entomol (2010) 0.87
Clinical validation of new pacing-sensing configurations for atrial automatic capture verification in pacemakers. J Cardiovasc Electrophysiol (2001) 0.87
Troglitazone inhibits angiotensin II-induced extracellular signal-regulated kinase 1/2 nuclear translocation and activation in vascular smooth muscle cells. FEBS Lett (1999) 0.87
Optical immunosensor for fast and sensitive detection of DDT and related compounds in river water samples. Biosens Bioelectron (2006) 0.87
Integrins alphavbeta3 and alphavbeta5 mediate VSMC migration and are elevated during neointima formation in the rat aorta. Basic Res Cardiol (2001) 0.87
The hormone melatonin stimulates renoprotective effects of "early outgrowth" endothelial progenitor cells in acute ischemic kidney injury. Am J Physiol Renal Physiol (2012) 0.87
Nitric oxide reduces organ injury and enhances regeneration of reduced-size livers by increasing hepatic arterial flow. Br J Surg (2008) 0.86
Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries. J Cardiovasc Pharmacol (1992) 0.86
Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans. J Am Coll Cardiol (2001) 0.86
ACE inhibitors are endothelium dependent vasodilators of coronary arteries during submaximal stimulation with bradykinin. Cardiovasc Res (1993) 0.86
High spatial resolution myocardial perfusion imaging during high dose dobutamine/atropine stress magnetic resonance using k-t SENSE. Int J Cardiol (2011) 0.86
Doxazosin inhibits retinoblastoma protein phosphorylation and G(1)-->S transition in human coronary smooth muscle cells. Arterioscler Thromb Vasc Biol (2000) 0.86
Myocardial cyclic AMP and norepinephrine content in human heart failure. Eur Heart J (1994) 0.85